Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.15
0.153.75%
At close: -
$4.15
0.000.00%
After Hours: Apr 4, 4:00 PM EDT
Comments
Loading...
Agilon Health Analyst Ratings and Price Targets | NYSE:AGL | Benzinga
Agilon Health Inc has a consensus price target of $8.63 based on the ratings of 27 analysts. The high is $33 issued by Truist Securities on July 14, 2022. The low is $2 issued by TD Cowen on November 11, 2024. The 3 most-recent analyst ratings were released by RBC Capital, Stifel, and Bernstein on February 26, 2025, February 26, 2025, and January 15, 2025, respectively. With an average price target of $3.22 between RBC Capital, Stifel, and Bernstein, there's an implied -22.49% downside for Agilon Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Stifel
Bernstein
Citigroup
Macquarie
1calculated from analyst ratings
Analyst Ratings for Agilon Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | Buy Now | — | Needham | Ryan MacDonald58% | — | Reiterates | Hold → Hold | Get Alert |
| 02/26/2025 | Buy Now | -15.66% | RBC Capital | Sean Dodge47% | $3 → $3.5 | Maintains | Outperform | Get Alert |
| 02/26/2025 | Buy Now | — | Citizens Capital Markets | Constantine Davides37% | — | Reiterates | Market Perform → Market Perform | Get Alert |
| 02/26/2025 | Buy Now | -27.71% | Stifel | Craig Jones60% | $2 → $3 | Maintains | Hold | Get Alert |
| 02/26/2025 | Buy Now | — | Needham | Ryan MacDonald58% | — | Reiterates | Hold → Hold | Get Alert |
| 01/15/2025 | Buy Now | -24.1% | Bernstein | Amir Farahan 1% | $2.5 → $3.15 | Maintains | Market Perform | Get Alert |
| 01/10/2025 | Buy Now | -45.78% | Citigroup | Daniel Grosslight43% | $1.75 → $2.25 | Upgrade | Sell → Neutral | Get Alert |
| 01/10/2025 | Buy Now | — | Needham | Matthew Sheerin67% | — | Reiterates | Hold → Hold | Get Alert |
| 12/16/2024 | Buy Now | -27.71% | Macquarie | Tao Qiu47% | → $3 | Initiates | → Neutral | Get Alert |
| 12/11/2024 | Buy Now | -39.76% | Bernstein | Lance Wilkes62% | → $2.5 | Initiates | → Market Perform | Get Alert |
| 11/19/2024 | Buy Now | -27.71% | RBC Capital | Sean Dodge47% | $3 → $3 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2024 | Buy Now | -57.83% | Citigroup | Daniel Grosslight43% | $2.5 → $1.75 | Maintains | Sell | Get Alert |
| 11/12/2024 | Buy Now | -51.81% | Stifel | Craig Jones60% | $7 → $2 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | -51.81% | TD Cowen | Gary Taylor60% | $6 → $2 | Maintains | Hold | Get Alert |
| 11/11/2024 | Buy Now | -51.81% | Barclays | Andrew Mok57% | $5 → $2 | Maintains | Underweight | Get Alert |
| 11/11/2024 | Buy Now | — | JMP Securities | Constantine Davides37% | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 11/08/2024 | Buy Now | — | William Blair | Ryan Daniels20% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 10/29/2024 | Buy Now | -39.76% | Citigroup | Daniel Grosslight43% | $7 → $2.5 | Downgrade | Neutral → Sell | Get Alert |
| 10/08/2024 | Buy Now | -3.61% | Evercore ISI Group | Elizabeth Anderson47% | $7 → $4 | Maintains | In-Line | Get Alert |
| 10/02/2024 | Buy Now | -27.71% | B of A Securities | Kevin Fischbeck67% | → $3 | Downgrade | Buy → Underperform | Get Alert |
| 08/09/2024 | Buy Now | -3.61% | Deutsche Bank | George Hill62% | $5 → $4 | Maintains | Hold | Get Alert |
| 08/08/2024 | Buy Now | 116.87% | Benchmark | Bill Sutherland63% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | Buy Now | 92.77% | RBC Capital | Sean Dodge47% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 07/09/2024 | Buy Now | 68.67% | Evercore ISI Group | Elizabeth Anderson47% | $5.5 → $7 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | 44.58% | Baird | Michael Halloran65% | → $6 | Initiates | → Neutral | Get Alert |
| 05/24/2024 | Buy Now | 56.63% | Truist Securities | Jailendra Singh38% | $6.4 → $6.5 | Maintains | Hold | Get Alert |
| 05/01/2024 | Buy Now | 68.67% | Stifel | Craig Jones60% | $8 → $7 | Maintains | Hold | Get Alert |
| 04/22/2024 | Buy Now | 44.58% | Citigroup | Daniel Grosslight43% | → $6 | Initiates | → Neutral | Get Alert |
| 04/15/2024 | Buy Now | 54.22% | Truist Securities | Jailendra Singh38% | $7.5 → $6.4 | Maintains | Hold | Get Alert |
| 03/06/2024 | Buy Now | 20.48% | Barclays | Andrew Mok57% | → $5 | Initiates | → Underweight | Get Alert |
| 02/29/2024 | Buy Now | 80.72% | Truist Securities | Jailendra Singh38% | $10 → $7.5 | Maintains | Hold | Get Alert |
| 02/29/2024 | Buy Now | 116.87% | Benchmark | Bill Sutherland63% | $13 → $9 | Maintains | Buy | Get Alert |
| 02/28/2024 | Buy Now | 44.58% | Evercore ISI Group | Elizabeth Anderson47% | $7 → $6 | Maintains | In-Line | Get Alert |
| 02/28/2024 | Buy Now | 92.77% | RBC Capital | Sean Dodge47% | $11 → $8 | Maintains | Outperform | Get Alert |
| 02/26/2024 | Buy Now | 92.77% | Wells Fargo | Stephen Baxter56% | $16 → $8 | Maintains | Overweight | Get Alert |
| 02/26/2024 | Buy Now | 56.63% | TD Cowen | Gary Taylor60% | $12 → $6.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/22/2024 | Buy Now | 116.87% | Stifel | Craig Jones60% | $10 → $9 | Maintains | Hold | Get Alert |
| 01/08/2024 | Buy Now | — | Wolfe Research | Justin Lake33% | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 01/05/2024 | Buy Now | 140.96% | Truist Securities | Jailendra Singh38% | $23 → $10 | Downgrade | Buy → Hold | Get Alert |
| 01/05/2024 | Buy Now | 116.87% | JP Morgan | Lisa Gill60% | $17 → $9 | Downgrade | Overweight → Neutral | Get Alert |
| 12/13/2023 | Buy Now | 309.64% | JP Morgan | Lisa Gill60% | $36 → $17 | Maintains | Overweight | Get Alert |
| 12/11/2023 | Buy Now | — | Goldman Sachs | Jamie Perse61% | — | Downgrade | Buy → Neutral | Get Alert |
| 12/06/2023 | Buy Now | 333.73% | JMP Securities | Constantine Davides37% | → $18 | Initiates | → Market Outperform | Get Alert |
| 11/21/2023 | Buy Now | 189.16% | Deutsche Bank | George Hill62% | $27 → $12 | Downgrade | Buy → Hold | Get Alert |
| 11/15/2023 | Buy Now | 430.12% | Benchmark | Bill Sutherland63% | $28 → $22 | Maintains | Buy | Get Alert |
| 11/13/2023 | Buy Now | 285.54% | Wells Fargo | Stephen Baxter56% | $23 → $16 | Maintains | Overweight | Get Alert |
| 11/09/2023 | Buy Now | 454.22% | Truist Securities | Jailendra Singh38% | $27 → $23 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | 430.12% | Goldman Sachs | Jamie Perse61% | $25 → $22 | Maintains | Buy | Get Alert |
| 11/03/2023 | Buy Now | 454.22% | RBC Capital | Sean Dodge47% | $28 → $23 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | 574.7% | Benchmark | Bill Sutherland63% | → $28 | Initiates | → Buy | Get Alert |
| 08/15/2023 | Buy Now | 502.41% | Goldman Sachs | Jamie Perse61% | $29 → $25 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | 502.41% | TD Cowen | Gary Taylor60% | $29 → $25 | Maintains | Outperform | Get Alert |
| 06/20/2023 | Buy Now | 550.6% | Truist Securities | Jailendra Singh38% | $35 → $27 | Maintains | Buy | Get Alert |
| 06/13/2023 | Buy Now | 442.17% | Evercore ISI Group | Elizabeth Anderson47% | → $22.5 | Initiates | → In-Line | Get Alert |
| 05/31/2023 | Buy Now | 598.8% | Goldman Sachs | Jamie Perse61% | $32 → $29 | Maintains | Buy | Get Alert |
| 05/15/2023 | Buy Now | 550.6% | Deutsche Bank | George Hill62% | $28 → $27 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 695.18% | RBC Capital | Sean Dodge47% | → $33 | Reiterates | → Outperform | Get Alert |
| 05/10/2023 | Buy Now | 671.08% | Stifel | Craig Jones60% | $29 → $20 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 743.37% | Truist Securities | Jailendra Singh38% | $29 → $35 | Maintains | Buy | Get Alert |
| 03/06/2023 | Buy Now | 622.89% | Guggenheim | Sandy Draper72% | $21 → $30 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | 574.7% | Deutsche Bank | George Hill62% | $26 → $28 | Maintains | Buy | Get Alert |
| 12/09/2022 | Buy Now | 454.22% | Stifel | Craig Jones60% | → $23 | Initiates | → Buy | Get Alert |
| 11/15/2022 | Buy Now | 719.28% | Goldman Sachs | Jamie Perse61% | $38 → $34 | Maintains | Buy | Get Alert |
| 11/15/2022 | Buy Now | 430.12% | Wells Fargo | Stephen Baxter56% | $28 → $22 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | 622.89% | SVB Leerink | Whit Mayo68% | $33 → $30 | Maintains | Outperform | Get Alert |
| 09/14/2022 | Buy Now | 695.18% | RBC Capital | Sean Dodge47% | → $33 | Initiates | → Outperform | Get Alert |
| 09/12/2022 | Buy Now | 815.66% | Goldman Sachs | Jamie Perse61% | → $38 | Initiates | → Buy | Get Alert |
| 09/07/2022 | Buy Now | 598.8% | Truist Securities | Jailendra Singh38% | $33 → $29 | Assumes | → Buy | Get Alert |
| 08/08/2022 | Buy Now | 574.7% | Wells Fargo | Stephen Baxter56% | $23 → $28 | Maintains | Overweight | Get Alert |
| 08/03/2022 | Buy Now | 622.89% | Deutsche Bank | George Hill62% | $29 → $30 | Maintains | Buy | Get Alert |
| 07/14/2022 | Buy Now | 695.18% | Truist Securities | David Macdonald68% | $30 → $33 | Maintains | Buy | Get Alert |
| 06/24/2022 | Buy Now | — | BTIG | David Larsen44% | — | Initiates | → Neutral | Get Alert |
| 06/08/2022 | Buy Now | 526.51% | Deutsche Bank | George Hill62% | $26 → $26 | Maintains | Buy | Get Alert |
| 05/10/2022 | Buy Now | 526.51% | Deutsche Bank | George Hill62% | → $26 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Agilon Health (AGL) stock?
The latest price target for Agilon Health (NYSE:AGL) was reported by Needham on March 21, 2025. The analyst firm set a price target for $0.00 expecting AGL to fall to within 12 months (a possible -100.00% downside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Agilon Health (AGL)?
The latest analyst rating for Agilon Health (NYSE:AGL) was provided by Needham, and Agilon Health reiterated their hold rating.
When was the last upgrade for Agilon Health (AGL)?
The last upgrade for Agilon Health Inc happened on January 10, 2025 when Citigroup raised their price target to $2.25. Citigroup previously had a sell for Agilon Health Inc.
When was the last downgrade for Agilon Health (AGL)?
The last downgrade for Agilon Health Inc happened on November 11, 2024 when JMP Securities changed their price target from N/A to N/A for Agilon Health Inc.
When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.
Is the Analyst Rating Agilon Health (AGL) correct?
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a reiterated with a price target of $0.00 to $0.00. The current price Agilon Health (AGL) is trading at is $4.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.